Discussion Genetic fusion of protein-based drugs to the N-terminal or C-terminal end of albumin, or both, offers a feasible and attractive approach to enhance the PK properties and therapeutic efficacy of short-lived biologics 6,7
Beyond its cosmetic benefits, it may also help reduce appetite and support weight management goals
discuss testing and options with a clinician
Topical ingredients like niacinamide may show visible improvements in skin texture relatively quickly, while glutathione works gradually by supporting skin health internally
Primary outcomes The primary outcomes are as follows: fatal and non-fatal CVD events, including coronary artery disease (CAD), ischemic stroke, heart failure, and atrial fibrillation (AF)